ASP-4058

N/A

Report date: 2023/02/12 17:21:23
NME

Base Information

Drug NameASP-4058
Drug Alias NameASP-4058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 agonistsSphingosine 1-phosphate receptor 2 agonists
TargetsSphingosine 1-Phosphate Receptor 1Sphingosine 1-phosphate receptor 2
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAstellas Pharma Global Development Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A